• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

光动力疗法中的自组装脂质体纳米颗粒。

Self-assembled liposomal nanoparticles in photodynamic therapy.

作者信息

Sadasivam Magesh, Avci Pinar, Gupta Gaurav K, Lakshmanan Shanmugamurthy, Chandran Rakkiyappan, Huang Ying-Ying, Kumar Raj, Hamblin Michael R

机构信息

Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA, USA.

Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA, USA; Department of Dermatology, Harvard Medical School, Boston, MA, USA; and Department of Dermatology, Dermatooncology and Venerology, Semmelweis University School of Medicine, Budapest, Hungary.

出版信息

Eur J Nanomed. 2013 Jul;5(3). doi: 10.1515/ejnm-2013-0010.

DOI:10.1515/ejnm-2013-0010
PMID:24348377
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3857307/
Abstract

Photodynamic therapy (PDT) employs the combination of non-toxic photosensitizers (PS) together with harmless visible light of the appropriate wavelength to produce reactive oxygen species that kill unwanted cells. Because many PS are hydrophobic molecules prone to aggregation, numerous drug delivery vehicles have been tested to solubilize these molecules, render them biocompatible and enhance the ease of administration after intravenous injection. The recent rise in nanotechnology has markedly expanded the range of these nanoparticulate delivery vehicles beyond the well-established liposomes and micelles. Self-assembled nanoparticles are formed by judicious choice of monomer building blocks that spontaneously form a well-oriented 3-dimensional structure that incorporates the PS when subjected to the appropriate conditions. This self-assembly process is governed by a subtle interplay of forces on the molecular level. This review will cover the state of the art in the preparation and use of self-assembled liposomal nanoparticles within the context of PDT.

摘要

光动力疗法(PDT)采用无毒光敏剂(PS)与适当波长的无害可见光相结合,产生活性氧以杀死不需要的细胞。由于许多PS是易于聚集的疏水分子,因此已经测试了多种药物递送载体来溶解这些分子,使其具有生物相容性并提高静脉注射后的给药便利性。纳米技术的最新发展显著扩展了这些纳米颗粒递送载体的范围,使其超越了成熟的脂质体和胶束。自组装纳米颗粒是通过明智地选择单体构建块形成的,这些单体在适当条件下会自发形成一个排列良好的三维结构,并将PS纳入其中。这种自组装过程受分子水平上各种力的微妙相互作用支配。本综述将涵盖在光动力疗法背景下自组装脂质体纳米颗粒的制备和应用的最新进展。

相似文献

1
Self-assembled liposomal nanoparticles in photodynamic therapy.光动力疗法中的自组装脂质体纳米颗粒。
Eur J Nanomed. 2013 Jul;5(3). doi: 10.1515/ejnm-2013-0010.
2
Photodynamic therapy: one step ahead with self-assembled nanoparticles.光动力疗法:自组装纳米粒子的一步领先。
J Biomed Nanotechnol. 2014 Sep;10(9):1937-52. doi: 10.1166/jbn.2014.1953.
3
Can nanotechnology potentiate photodynamic therapy?纳米技术能增强光动力疗法吗?
Nanotechnol Rev. 2012 Mar;1(2):111-146. doi: 10.1515/ntrev-2011-0005.
4
Nanoformulation of Tetrapyrroles Derivatives in Photodynamic Therapy: A Focus on Bacteriochlorin.光动力疗法中四吡咯衍生物的纳米制剂:聚焦于细菌叶绿素。
Evid Based Complement Alternat Med. 2022 Sep 30;2022:3011918. doi: 10.1155/2022/3011918. eCollection 2022.
5
Liposomal nanostructures for photosensitizer delivery.用于递送光敏剂的脂质体纳米结构。
Lasers Surg Med. 2011 Sep;43(7):734-48. doi: 10.1002/lsm.21101.
6
Nanotechnology for photodynamic therapy: a perspective from the Laboratory of Dr. Michael R. Hamblin in the Wellman Center for Photomedicine at Massachusetts General Hospital and Harvard Medical School.用于光动力疗法的纳米技术:来自马萨诸塞州总医院和哈佛医学院威尔曼光医学中心迈克尔·R·哈姆林博士实验室的观点。
Nanotechnol Rev. 2015 Aug;4(4):359-372. doi: 10.1515/ntrev-2015-0027. Epub 2015 Aug 7.
7
Water-Soluble, Zwitterionic Poly-photosensitizers as Carrier-Free, Photosensitizer-Self-Delivery System for in Vivo Photodynamic Therapy.水溶性两性离子多光增敏剂作为无载体、光增敏剂自递药系统用于体内光动力治疗。
ACS Appl Mater Interfaces. 2019 Nov 27;11(47):44007-44017. doi: 10.1021/acsami.9b19546. Epub 2019 Nov 19.
8
Synthesis of Self-Assembled Porphyrin Nanoparticle Photosensitizers.自组装卟啉纳米颗粒光增敏剂的合成。
ACS Nano. 2018 Apr 24;12(4):3796-3803. doi: 10.1021/acsnano.8b01010. Epub 2018 Apr 11.
9
Self-Assembly of Monomeric Hydrophobic Photosensitizers with Short Peptides Forming Photodynamic Nanoparticles with Real-Time Tracking Property and without the Need of Release in Vivo.单体疏水性光敏剂与短肽的自组装形成具有实时跟踪性能且无需体内释放的光动力纳米粒子。
ACS Appl Mater Interfaces. 2018 Aug 29;10(34):28420-28427. doi: 10.1021/acsami.8b09933. Epub 2018 Aug 15.
10
Bioactivatable reactive oxygen species-sensitive nanoparticulate system for chemo-photodynamic therapy.用于化学-光动力治疗的生物激活型活性氧敏感纳米颗粒系统。
Acta Biomater. 2020 May;108:273-284. doi: 10.1016/j.actbio.2020.03.027. Epub 2020 Mar 21.

引用本文的文献

1
Can Cisplatin Therapy Be Improved? Pathways That Can Be Targeted.顺铂治疗能否得到改善?可以靶向的途径。
Int J Mol Sci. 2022 Jun 29;23(13):7241. doi: 10.3390/ijms23137241.
2
Milk exosomes-mediated miR-31-5p delivery accelerates diabetic wound healing through promoting angiogenesis.牛奶外泌体介导的 miR-31-5p 递呈通过促进血管生成加速糖尿病创面愈合。
Drug Deliv. 2022 Dec;29(1):214-228. doi: 10.1080/10717544.2021.2023699.
3
Nanoparticle-Mediated Delivery Systems in Photodynamic Therapy of Colorectal Cancer.纳米颗粒介导的递药系统在结直肠癌光动力治疗中的应用。

本文引用的文献

1
Mechanisms in photodynamic therapy: part one-photosensitizers, photochemistry and cellular localization.光动力疗法的机制:第一部分——光敏剂、光化学和细胞定位。
Photodiagnosis Photodyn Ther. 2004 Dec;1(4):279-93. doi: 10.1016/S1572-1000(05)00007-4.
2
A new nanoconstruct for epidermal growth factor receptor-targeted photo-immunotherapy of ovarian cancer.一种用于表皮生长因子受体靶向光免疫治疗卵巢癌的新型纳米构建体。
Nanomedicine. 2013 Oct;9(7):1114-22. doi: 10.1016/j.nano.2013.02.005. Epub 2013 Feb 26.
3
Functional characterization of Fospeg, and its impact on cell cycle upon PDT of Huh7 hepatocellular carcinoma cell model.
Int J Mol Sci. 2021 Nov 17;22(22):12405. doi: 10.3390/ijms222212405.
4
Antimicrobial photodynamic therapy (aPDT) for biofilm treatments. Possible synergy between aPDT and pulsed electric fields.抗菌光动力疗法 (aPDT) 治疗生物膜。aPDT 与脉冲电场的协同作用。
Virulence. 2021 Dec;12(1):2247-2272. doi: 10.1080/21505594.2021.1960105.
5
Multi-Functional Liposome: A Powerful Theranostic Nano-Platform Enhancing Photodynamic Therapy.多功能脂质体:增强光动力治疗的强大治疗诊断一体化纳米平台。
Adv Sci (Weinh). 2021 Aug;8(16):e2100876. doi: 10.1002/advs.202100876. Epub 2021 Jun 3.
6
Probing the Interactions of Porphyrins with Macromolecules Using NMR Spectroscopy Techniques.利用 NMR 光谱技术探测卟啉与生物大分子的相互作用。
Molecules. 2021 Mar 30;26(7):1942. doi: 10.3390/molecules26071942.
7
Progress in Clinical Trials of Photodynamic Therapy for Solid Tumors and the Role of Nanomedicine.实体肿瘤光动力治疗的临床试验进展及纳米医学的作用
Cancers (Basel). 2020 Sep 29;12(10):2793. doi: 10.3390/cancers12102793.
8
Novel nanomaterial-based antibacterial photodynamic therapies to combat oral bacterial biofilms and infectious diseases.基于新型纳米材料的抗菌光动力疗法,以对抗口腔细菌生物膜和感染性疾病。
Int J Nanomedicine. 2019 Aug 28;14:6937-6956. doi: 10.2147/IJN.S212807. eCollection 2019.
9
Liposomal formulations of photosensitizers.脂质体剂型的光敏剂。
Biomaterials. 2019 Oct;218:119341. doi: 10.1016/j.biomaterials.2019.119341. Epub 2019 Jul 10.
10
Advances in antimicrobial photodynamic inactivation at the nanoscale.纳米尺度下抗菌光动力灭活的进展。
Nanophotonics. 2017 Aug;6(5):853-879. doi: 10.1515/nanoph-2016-0189. Epub 2017 Aug 1.
研究 Fospeg 的功能特性及其对 Huh7 肝癌细胞模型光动力治疗后细胞周期的影响。
Photodiagnosis Photodyn Ther. 2013 Feb;10(1):87-94. doi: 10.1016/j.pdpdt.2012.05.006. Epub 2012 Jul 6.
4
Crosslinked multilamellar liposomes for controlled delivery of anticancer drugs.交联多层脂质体用于控制抗癌药物的递送。
Biomaterials. 2013 Apr;34(12):3098-109. doi: 10.1016/j.biomaterials.2013.01.039. Epub 2013 Jan 30.
5
Choroidal neovascularization reduced by targeted drug delivery with cationic liposome-encapsulated paclitaxel or targeted photodynamic therapy with verteporfin encapsulated in cationic liposomes.阳离子脂质体包裹的紫杉醇靶向给药或阳离子脂质体包裹的维替泊芬靶向光动力疗法可减少脉络膜新生血管形成。
Mol Vis. 2013;19:54-61. Epub 2013 Jan 10.
6
Mechanism of self-assembly in the synthesis of silica mesoporous materials: in situ studies by X-ray and neutron scattering.介孔二氧化硅材料合成中的自组装机制:X 射线和中子散射的原位研究。
Chem Soc Rev. 2013 May 7;42(9):4071-82. doi: 10.1039/c2cs35362h. Epub 2012 Dec 21.
7
Comparative characterization of the cellular uptake and photodynamic efficiency of Foscan® and Fospeg in a human prostate cancer cell line.福司坎®和福铁龙在人前列腺癌细胞系中的细胞摄取和光动力效率的比较表征。
Photodiagnosis Photodyn Ther. 2012 Dec;9(4):344-54. doi: 10.1016/j.pdpdt.2012.03.008. Epub 2012 May 3.
8
Temoporfin mediated photodynamic therapy in patients with local persistent and recurrent nasopharyngeal carcinoma after curative radiotherapy: a feasibility study.替莫泊芬介导的光动力疗法在根治性放疗后局部持续性和复发性鼻咽癌患者中的应用:一项可行性研究。
Photodiagnosis Photodyn Ther. 2012 Sep;9(3):274-81. doi: 10.1016/j.pdpdt.2012.07.002. Epub 2012 Aug 23.
9
Efficacy and safety of photodynamic therapy with temoporfin in curative treatment of recurrent carcinoma of the oral cavity and oropharynx.替莫泊芬光动力疗法治疗复发性口腔和口咽癌的疗效和安全性。
Eur Arch Otorhinolaryngol. 2013 Mar;270(4):1433-9. doi: 10.1007/s00405-012-2083-7. Epub 2012 Aug 29.
10
Long-term outcomes following Foscan®-PDT of basal cell carcinomas.基底细胞癌经Foscan®光动力疗法后的长期疗效。
Lasers Surg Med. 2012 Sep;44(7):533-40. doi: 10.1002/lsm.22056. Epub 2012 Jul 31.